Jump to Main Contents
先端医療開発センター

Home > Publications

Publications

2016

  1. Nakamura S, Okamoto H, Wakita A, Umezawa R, Takahashi K, Inaba K, Murakami N, Kato T, Igaki H, Ito Y, Abe Y, Itami J. A management method for the statistical results of patient-specific quality assurance for intensity-modulated radiation therapy. J Radiat Res. 2016 Nov 10.
  2. Murakami N, Kobayashi K, Kato T, Nakamura S, Wakita A, Okamoto H, Shima S, Tsuchida K, Kashihara T, Harada K, Takahashi K, Umezawa R, Inaba K, Ito Y, Igaki H, Itami J. The role of interstitial brachytherapy in the management of primary radiation therapy for uterine cervical cancer. J Contemp Brachytherapy. 2016 Oct;8(5):391-398.
  3. Kobayashi K, Matsumoto F, Kodaira M, Mori T, Murakami N, Yoshida A, Maki D, Teshima M, Fukasawa M, Itami J, Asai M, Yoshimoto S. Significance of delayed primary excision in localized nonmetastatic adult head and neck rhabdomyosarcoma. Cancer Med. 2016 Oct;5(10):2708-2714.
  4. Nose T, Otani Y, Asahi S, Tsukiyama I, Dokiya T, Saeki T, Fukuda I, Sekine H, Shikama N, Kumazaki Y, Takahashi T, Yoshida K, Kotsuma T, Masuda N, Yoden E, Nakashima K, Matsumura T, Nakagawa S, Tachiiri S, Moriguchi Y, Itami J, Oguchi M. A Japanese prospective multi-institutional feasibility study on accelerated partial breast irradiation using interstitial brachytherapy: clinical results with a median follow-up of 26 months. Breast Cancer. 2016 Nov;23(6):861-868.
  5. Kawajiri A, Maruyama D, Maeshima AM, Nomoto J, Makita S, Kitahara H, Miyamoto KI, Fukuhara S, Suzuki T, Munakata W, Tajima K, Itami J, Taniguchi H, Kobayashi Y, Tobinai K. Impact of the double expression of MYC and BCL2 on outcomes of localized primary gastric diffuse large B-cell lymphoma patients in the rituximab era. Blood Cancer J. 2016 Sep 30;6(9):e477.
  6. Takahashi K, Morota M, Kagami Y, Okamoto H, Sekii S, Inaba K, Murakami N, Igaki H, Ito Y, Uno T, Itami J. Prospective study of postoperative whole breast radiotherapy for Japanese large-breasted women: a clinical and dosimetric comparisons between supine and prone positions and a dose measurement using a breast phantom. BMC Cancer. 2016 Sep 29;16(1):757.
  7. Okamoto H, Wakita A, Nakamura S, Nishioka S, Aikawa A, Kato T, Abe Y, Kobayashi K, Inaba K, Murakami N, Itami J. Dosimetric impact of an air passage on intraluminal brachytherapy for bronchus cancer. J Radiat Res. 2016 Sep 7.
  8. Murakami N, Kato S, Nakano T, Uno T, Yamanaka T, Sakurai H, Yoshimura R, Hiratsuka J, Kuroda Y, Yoshio K, Itami J. A phase I/II clinical trial for the hybrid of intracavitary and interstitial brachytherapy for locally advanced cervical cancer. BMC Cancer. 2016 Aug 17;16:640. doi: 10.1186/s12885-016-2543-3.
  9. Kobayashi K, Kurihara H, Watanabe Y, Murakami N, Inaba K, Nakamura S, Wakita A, Okamoto H, Umezawa R, Takahashi K, Igaki H, Ito Y, Yoshimoto S, Shigematsu N, Itami J. In vivo spatial correlation between (18)F-BPA and (18)F-FDG uptakes in head and neck cancer. Appl Radiat Isot. 2016 Sep;115:138-46. doi: 10.1016/j.apradiso.2016.05.026.
  10. Inaba K, Okamoto H, Wakita A, Tsuchida K, Kashihara T, Kobayashi K, Harada K, Kitaguchi M, Sekii S, Umezawa R, Takahashi K, Murakami N, Ito Y, Igaki H, Uno T, Itami J. Long-term observations of radiation-induced creatinine clearance reduction and renal parenchymal volume atrophy. Radiother Oncol. 2016 Jul;120(1):145-9. doi: 10.1016/j.radonc.2016.04.022.
  11. Kobayashi K, Murakami N, Inaba K, Wakita A, Nakamura S, Okamoto H, Sato J, Umezawa R, Takahashi K, Igaki H, Ito Y, Shigematsu N, Itami J. Dose reconstruction technique using non-rigid registration to evaluate spatial correspondence between high-dose region and late radiation toxicity: a case of tracheobronchial stenosis after external beam radiotherapy combined with endotracheal brachytherapy for tracheal cancer. J Contemp Brachytherapy. 2016 Apr;8(2):156-63. doi: 10.5114/jcb.2016.59688.
  12. Nakamura S, Murakami N, Inaba K, Wakita A, Kobayashi K, Takahashi K, Okamoto H, Umezawa R, Morota M, Sumi M, Igaki H, Ito Y, Itami J. After low and high dose-rate interstitial brachytherapy followed by IMRT radiotherapy for intermediate and high risk prostate cancer. BMC Cancer. 2016 May 3;16:296. doi: 10.1186/s12885-016-2329-7.
  13. Murakami N, Kato T, Miyamoto Y, Nakamura S, Wakita A, Okamoto H, Tsuchida K, Kashihara T, Kobayashi K, Harada K, Kitaguchi M, Sekii S, Takahashi K, Umezawa R, Inaba K, Ito Y, Igaki H, Itami J. Salvage High-dose-rate Interstitial Brachytherapy for Pelvic Recurrent Cervical Carcinoma After Hysterectomy. Anticancer Res. 2016 May;36(5):2413-21.
  14. Okamoto H, Hamada M, Sakamoto E, Wakita A, Nakamura S, Kato T, Abe Y, Takahashi K, Igaki H, Itami J. Log-file analysis of accuracy of beam localization for brain tumor treatment by CyberKnife. Pract Radiat Oncol. 2016 Jan 26. pii: S1879-8500(16)00010-2. doi: 10.1016/j.prro.2016.01.008.
  15. Murakami N, Matsumoto F, Yoshimoto S, Ito Y, Mori T, Ueno T, Tuchida K, Kashihara T, Kobayashi K, Harada K, Kitaguchi M, Sekii S, Umezawa R, Takahashi K, Inaba K, Igaki H, Itami J. Patterns of recurrence after selective postoperative radiation therapy for patients with head and neck squamous cell carcinoma. BMC Cancer. 2016 Mar 7;16:192. doi: 10.1186/s12885-016-2229-x.
  16. Watanabe T, Ueno H, Watabe Y, Hiraoka N, Morizane C, Itami J, Okusaka T, Miura N, Kakizaki T, Kakuya T, Kamita M, Tsuchida A, Nagakawa Y, Wilber H, Yamada T, Honda K. ACTN4 copy number increase as a predictive biomarker for chemoradiotherapy of locally advanced pancreatic cancer. Br J Cancer 2015;112:704-13.
  17. Murakami N, Okamoto H, Isohashi F, Murofushi K, Ohno T, Yoshida D, Saito M, Inaba K, Ito Y, Toita T, Itami J: A surveillance study of intensity-modulated radiation therapy for postoperative cervical cancer in Japan. J Radiat Res 2015 Jul;56(4):735-41. doi: 10.1093/jrr/rrv020.
  18. Murakami N, Kobayashi K, Nakamura S, Wakita A, Okamoto H, Tsuchida K, Kashihara T, Harada K, Yamada M, Sekii S, Takahashi K, Umezawa R, Inaba K, Ito Y, Igaki H, Itami J: A total EQD2 greater than 85 Gy for trachea and main bronchus D2cc being associated with severe late complications after definitive endobronchial brachytherapy. J Contemp Brachytherapy 2015 Oct;7(5):363-8. doi: 10.5114/jcb.2015.54968. Epub 2015 Oct 13.
  19. Kobayashi K, Murakami N, Wakita A, Nakamura S, Okamoto H, Umezawa R, Takahashi K, Inaba K, Igaki H, Ito Y, Shigematsu N, Itami J: Dosimetric variations due to interfraction organ deformation in cervical cancer brachytherapy. Radiother Oncol 2015 Aug 24. pii: S0167-8140(15)00442-9. doi: 10.1016/j.radonc.2015.08.017
  20. Sato A, Itoh T, Imamichi S, Kikuhara S, Fujimori H, Hirai T, Saito S, Sakurai Y, Tanaka H, Nakamura H, Suzuki M, Murakami Y, Baiseitov D, Berikkhanova K, Zhumadilov Z, Imahori Y, Itami J, Ono K, Masunaga S, Masutani M: Proteomic analysis of cellular response induced by boron neutron capture reaction in human squamous cell carcinoma SAS cells. Appl Radiat Isot 2015 Dec;106:213-9. doi: 10.1016/j.apradiso.2015.08.001.
  21. Murakami N, Kühnel A, Schmid TE, Ilicic K, Stangl S, Braun IS, Gehrmann M, Molls M, Itami J, Multhoff G: Role of membrane Hsp70 in radiation sensitivity of tumor cells. Radiat Oncol 2015 Jul 22;10:149. doi: 10.1186/s13014-015-0461-1.
  22. Watanabe H, Maehara Y, Fujibuchi T, Koizumi M, Yamaguchi I, Kida T, Ooyama M, Horitsugi G, Hiraki H, Tsukamoto A, Itami J: Assessing the Effectiveness of Risk Communication for Maintenance Workers Who Deal With Induced Radioactivity Management of Medical Linear Accelerators. Health Phys 2015 Aug;109(2):145-56. doi: 10.1097/HP.0000000000000306. Erratum in: Health Phys. 2015 Oct;109(4):330.
  23. Otani Y, Nose T, Dokiya T, Saeki T, Kumazaki Y, Asahi S, Tsukiyama I, Fukuda I, Sekine H, Shikama N, Takahashi T, Yoshida K, Kotsuma T, Masuda N, Yoden E, Nakashima K, Matsumura T, Nakagawa S, Tachiiri S, Moriguchi Y, Itami J, Oguchi M: A Japanese prospective multi-institutional feasibility study on accelerated partial breast irradiation using interstitial brachytherapy: treatment planning and quality assurance. Radiat Oncol 2015 Jun 4;10:126. doi: 10.1186/s13014-015-0430-8.
  24. Murakami N, Kasamatsu T, Sumi M, Yoshimura R, Harada K, Kitaguchi M, Sekii S, Takahashi K, Yoshio K, Inaba K, Morota M, Ito Y, Itami J. Vaginal tolerance of CT based image-guided high-dose rate interstitial brachytherapy for gynecological malignancies. Radiat Oncol 2014;9:31. doi: 10.1186/1748-717X-9-31.
  25. Okamoto H, Fujita Y, Sakama K, Saitoh H, Kanai T, Itami J, Kohno T. Commissioning of 6 MV medical linac for dynamic MLC-based IMRT on Monte Carlo code GEANT4. Radiol Phys Technol 2014;7:246-53.
  26. Harada K, Murakami N, Kitaguchi M, Sekii S, Takahashi K, Yoshio K, Inaba K, Morota M, Ito Y, Sumi M, Suzuki S, Tobinai K, Uno T, Itami J. Localized ocular adnexal mucosa-associated lymphoid tissue lymphoma treated with radiation therapy: a long-term outcome in 86 patients with 104 treated eyes. Int J Radiat Oncol Biol Phys 2014;88:650-4.
  27. Okamoto H, Aikawa A, Wakita A, Yoshio K, Murakami N, Nakamura S, Hamada M, Abe Y, Itami J. Dose error from deviation of dwell time and source position for high dose-rate 192Ir in remote afterloading system. J Radiat Res 2014;55:780-7.
  28. Masutani M, Baiseitov D, Itoh T, Hirai T, Berikkhanova K, Murakami Y, Zhumadilov Z, Imahori Y, Hoshi M, Itami J. Histological and biochemical analysis of DNA damage after BNCT in rat model. Appl Radiat Isot 2014;88:104-8.
  29. Murakami N, Kasamatsu T, Wakita A, Nakamura S, Okamoto H, Inaba K, Morota M, Ito Y, Sumi M, Itami J. CT based three dimensional dose-volume evaluations for high-dose rate intracavitary brachytherapy for cervical cancer. BMC Cancer 2014;14:447. doi: 10.1186/1471-2407-14-447.
  30. Fujibuchi T, Yonai S, Yoshida M, Sakae T, Watanabe H, Abe Y, Itami J. Measurement of activity distribution using photostimulable phosphor imaging plates in decommissioned 10 MV medical linear accelerator. Health Phys 2014;107(2 Suppl 2):S158-62.
  31. Murakami N, Mori T, Yoshimoto S, Ito Y, Kobayashi K, Ken H, Kitaguchi M, Sekii S, Takahashi K, Yoshio K, Inaba K, Morota M, Sumi M, Itami J. Expression of EpCAM and prognosis in early-stage glottic cancer treated by radiotherapy. Laryngoscope 2014;124:E431-6.
  32. Murakami N, Yoshimoto S, Matsumoto F, Ueno T, Ito Y, Watanabe S, Kobayashi K, Harada K, Kitaguchi M, Sekii S, Takahashi K, Yoshio K, Inaba K, Morota M, Sumi M, Saito Y, Itami J. Severe gastrointestinal bleeding in patients with locally advanced head and neck squamous cell carcinoma treated by concurrent radiotherapy and Cetuximab. J Cancer Res Clin Oncol 2015;141:177-84.
  33. Inaba K, Okamoto H, Wakita A, Nakamura S, Kobayashi K, Harada K, Kitaguchi M, Sekii S, Takahashi K, Yoshio K, Murakami N, Morota M, Ito Y, Sumi M, Uno T, Itami J. Radiotherapy for gastric lymphoma: a planning study of 3D conformal radiotherapy, the half-beam method, and intensity-modulated radiotherapy. J Radiat Res 2014;55:1141-5.
  34. Satoh T, Dokiya T, Yamanaka H, Saito S, Ishiyama H, Itami J, Shibuya H, Nakano T, Shigematsu N, Aoki M, Egawa S, Hashimoto M, Nishimura T, Yorozu A. Postmortem radiation safety and issues pertaining to permanent prostate seed implantation in Japan. Brachytherapy 2015;14:136-141.
  35. Murakami N, Okamoto H, Kasamatsu T, Kobayashi K, Harada K, Kitaguchi M, Sekii S, Takahashi K, Yoshio K, Inaba K, Morota M, Sumi M, Toita T, Ito Y, Itami J. A dosimetric analysis of intensity-modulated radiation therapy with bone marrow sparing for cervical cancer. Anticancer Res 2014;34:5091-8.
  36. Tani H, Kurihara H, Hiroi K, Honda N, Yoshimoto M, Kono Y, Murakami R, Kumita S, Arai Y, Itami J. Correlation of (18)F-BPA and (18)F-FDG uptake in head and neck cancers. Radiother Oncol 2014;113:193-7.